Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2025 Earnings Call Transcript

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2025 Earnings Call Transcript August 6, 2025

Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $-2.27, expectations were $-2.72.

Operator: Good morning, and welcome to the Seres Therapeutics Second Quarter 2025 Results and Business Update Call. [Operator Instructions] Please note, this call is being recorded. I would now like to turn the conference over to Dr. Carlo Tanzi, of Investor Relations. Please go ahead.

Carlo Tanzi: Thank...